Luque-Ramírez, M <br/><br/>
Treatment of polycystic ovary syndrome (PCOS) with metformin ameliorates insulin resistance in parallel with the decrease of serum interleukin-6 concentrations.  [electronic resource] 

 -  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme  Oct 2010 
 - 815-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1439-4286 
<br/><br/><label>Standard No.: </label>10.1055/s-0030-1262855  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Female<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin Resistance<br/>Interleukin-18--blood<br/>Interleukin-6--blood<br/>Metformin--therapeutic use<br/>Polycystic Ovary Syndrome--blood